Kafka-Ritsch Reinhold, Zitt Matthias, Perathoner Alexander, Gasser Elisabeth, Kaufman Claudia, Czipin Sasha, Aigner Felix, Öfner Dietmar
Department of Visceral, Transplant and Thoracic Surgery, Centre for Operative Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Department of Surgery, Dornbirn General Hospital, Dornbirn, Austria.
World J Surg. 2020 Dec;44(12):4098-4105. doi: 10.1007/s00268-020-05762-1. Epub 2020 Sep 8.
Damage control surgery (DCS) with abdominal negative pressure therapy and delayed anastomosis creation in patients with perforated diverticulitis and generalized peritonitis was established at our Institution in 2006 and has been published. The concept was adopted in other hospitals and published as a case series. This is the first prospectively controlled randomized study comparing DCS and conventional treatment (Group C) in this setting.
All consecutive patients from 2013 to 2018 with indication for surgery were screened and randomized to Group DCS or Group C. The primary outcome was the rate of reconstructed bowel at discharge and at 6 month. Informed consent was obtained. The trial was approved by the local ethics committee and registered at CinicalTrials.gov: NCT04034407.
A total of 56 patients were screened; 41 patients gave informed consent to participate and ultimately 21 patients (9 female) with intraoperatively confirmed Hinchey III (n = 14, 67%) or IV (n = 7, 33%), and a median (range) age of 66 (42-92), Mannheim Peritonitis Index of 25 (12-37) and Charlson Comorbidity Index of 3 (0-10) were intraoperatively randomized and treated as Group DCS (n = 13) or Group C (n = 8). Per protocol analysis: A primary anastomosis without ileostomy (PA) was performed in 92% (11/12) patients in Group DCS at the second-look operation, one patient died before second look, and one underwent a Hartmann procedure (HP). In Group C 63% (5/8) patients received a PA and 38% (3/8) patients a HP. Two patients in Group C, but none in Group DCS experienced anastomotic leakage (AI). ICU and hospital stay was median (range) 2 (1-10) and 17.5 (12-43) in DCS and 2 (1-62) and 22 (13-65) days in group C. In Group DCS 8% (1/12) patients was discharged with a stoma versus 57% (4/7) in Group C (p = 0.038, n.s., α = 0.025); one patient died before discharge. The odds ratio (95% confidence interval) for discharge with a stoma is 0.068 (0.005-0.861). Intent to treat analysis: A PA was performed in 90% (9/10) of patients randomized to DCS, one patient died before the second look, and one patient received a HP. In group C, 70% (7/10) were treated with PA and 30% (3/10) with HP. 29% (2/7) experienced AI treated with protective ileostomy. In group DCS, 9% (1/11) were discharged with a stoma versus 40% (4/10) in group C (p = 0.14, n.s.). The odds ratio for discharge with a stoma is 0.139 (0.012-1.608).
This is the first prospectively randomized controlled study showing that damage control surgery in perforated diverticulitis Hinchey III and IV enhances reconstruction of bowel continuity and can reduce the stoma rate at discharge.
2006年我院开展了对穿孔性憩室炎合并弥漫性腹膜炎患者采用腹部负压治疗及延迟吻合术的损伤控制手术(DCS),并已发表相关研究。这一理念在其他医院也被采用,并作为病例系列发表。这是第一项在此种情况下比较DCS与传统治疗(C组)的前瞻性对照随机研究。
对2013年至2018年所有有手术指征的连续患者进行筛查,并随机分为DCS组或C组。主要结局指标为出院时及6个月时肠道重建率。获得了知情同意。该试验经当地伦理委员会批准,并在ClinicalTrials.gov注册:NCT04034407。
共筛查56例患者;41例患者签署知情同意书参与研究,最终21例患者(9例女性)术中确诊为Hinchey III级(n = 14,67%)或IV级(n = 7,33%),中位(范围)年龄66岁(42 - 92岁),曼海姆腹膜炎指数为25(12 - 37),查尔森合并症指数为3(0 - 10),术中随机分为DCS组(n = 13)或C组(n = 8)并接受相应治疗。按方案分析:DCS组92%(11/12)患者在二次探查手术时进行了无回肠造口的一期吻合(PA),1例患者在二次探查前死亡,1例接受了哈特曼手术(HP)。C组63%(5/8)患者接受了PA,38%(3/8)患者接受了HP。C组有2例患者发生吻合口漏(AI),而DCS组无。DCS组ICU住院时间和总住院时间的中位数(范围)分别为2天(1 - 10天)和17.5天(12 - 43天),C组分别为2天(1 - 62天)和22天(13 - 65天)。DCS组8%(1/12)患者出院时带造口,C组为57%(4/7)(p = 0.038,无统计学意义,α = 0.025);1例患者在出院前死亡。出院时带造口的比值比(95%置信区间)为0.068(0.005 - 0.861)。意向性分析:随机分配至DCS组的患者中90%(9/10)进行了PA,1例患者在二次探查前死亡,1例患者接受了HP。C组中,70%(7/10)接受PA治疗,30%(3/10)接受HP治疗。29%(2/7)发生AI的患者接受了保护性回肠造口术。DCS组9%(1/11)患者出院时带造口,C组为40%(4/10)(p = 0.14,无统计学意义)。出院时带造口的比值比为0.139(0.012 - 1.608)。
这是第一项前瞻性随机对照研究,表明对Hinchey III级和IV级穿孔性憩室炎采用损伤控制手术可提高肠道连续性重建率,并可降低出院时的造口率。